Literature DB >> 23867965

Ages and Stages Questionnaires-3 developmental screening of infants and young children with cancer.

Troy C Quigg1, Arash Mahajerin, Paula D Sullivan, Kamnesh Pradhan, Nerissa S Bauer.   

Abstract

The Ages and Stages Questionnaires-3® (ASQ-3) for developmental screening in our young oncology patients was pilot tested in children 4 to 48 months of age with newly diagnosed cancer. Subjects were screened within 28 days of diagnosis (baseline), at 6 and 12 months. Twenty-six of 30 enrolled parents (87%) completed all 3 screens. Screens were completed by parents within 15 minutes. ASQ-3 screening identified unsuspected developmental delays as follows: 7 at baseline, 4 at 6 months, and 3 at 12 months. ASQ-3 developmental screening is feasible, identifies early developmental delays in young children with cancer, and helps initiate appropriate referrals.

Entities:  

Keywords:  Ages and Stages Questionnaires-3® (ASQ-3); developmental delay; developmental screening; neurocognitive delay

Mesh:

Year:  2013        PMID: 23867965      PMCID: PMC4026287          DOI: 10.1177/1043454213493510

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  21 in total

Review 1.  Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.

Authors:  Paul C Nathan; Sunita K Patel; Kimberley Dilley; Robert Goldsby; Jeanne Harvey; Chad Jacobsen; Nina Kadan-Lottick; Karen McKinley; Anne K Millham; Ida Moore; M Fatih Okcu; Catherine L Woodman; Pim Brouwers; F Daniel Armstrong
Journal:  Arch Pediatr Adolesc Med       Date:  2007-08

2.  Models of care for survivors of childhood cancer.

Authors:  Debra L Friedman; David R Freyer; Gill A Levitt
Journal:  Pediatr Blood Cancer       Date:  2006-02       Impact factor: 3.167

3.  Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening.

Authors: 
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Revision of a parent-completed development screening tool: Ages and Stages Questionnaires.

Authors:  J Squires; D Bricker; L Potter
Journal:  J Pediatr Psychol       Date:  1997-06

5.  Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: can it be done?

Authors:  Leanne Embry; Robert D Annett; Alicia Kunin-Batson; Sunita K Patel; Stephen Sands; Gregory Reaman; Robert B Noll
Journal:  Pediatr Blood Cancer       Date:  2012-05-03       Impact factor: 3.167

6.  Late effects of treatment in survivors of childhood acute myeloid leukemia.

Authors:  W Leung; M M Hudson; D K Strickland; S Phipps; D K Srivastava; R C Ribeiro; J E Rubnitz; J T Sandlund; L E Kun; L C Bowman; B I Razzouk; P Mathew; P Shearer; W E Evans; C H Pui
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

7.  Parents' concerns about children's development: prescreening technique or screening test?

Authors:  F P Glascoe
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

Review 8.  Neurologic complications of chemotherapy for children with cancer.

Authors:  Alyssa T Reddy; Kerry Witek
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 9.  Parents of children with chronic health problems: programs of nursing research and their relationship to developmental science.

Authors:  Margaret Shandor Miles
Journal:  Annu Rev Nurs Res       Date:  2003

Review 10.  Enhancing nursing research with children and families using a developmental science perspective.

Authors:  Margaret Shandor Miles; Diane Holditch-Davis
Journal:  Annu Rev Nurs Res       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.